-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Denali Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q4 2018 to Q3 2024.
- Denali Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 169M shares, a 23.1% increase year-over-year.
- Denali Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 137M shares, a 9.43% increase from 2022.
- Denali Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 126M shares, a 3.3% increase from 2021.
- Denali Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 122M shares, a 7.83% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)